 Robert Ryu
Concepts (485)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 24 | 2023 | 60 | 6.630 |
Why?
| | Liver Neoplasms | 60 | 2014 | 635 | 3.600 |
Why?
| | Embolization, Therapeutic | 44 | 2020 | 207 | 3.450 |
Why?
| | Device Removal | 18 | 2023 | 136 | 3.260 |
Why?
| | Yttrium Radioisotopes | 40 | 2020 | 52 | 2.950 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 10 | 2021 | 41 | 2.900 |
Why?
| | Carcinoma, Hepatocellular | 41 | 2014 | 270 | 2.830 |
Why?
| | Radiology, Interventional | 6 | 2024 | 30 | 2.540 |
Why?
| | Pulmonary Embolism | 11 | 2021 | 212 | 1.940 |
Why?
| | Radiography, Interventional | 17 | 2016 | 105 | 1.720 |
Why?
| | Chemoembolization, Therapeutic | 21 | 2014 | 48 | 1.620 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 37 | 1.560 |
Why?
| | Hypertension, Portal | 5 | 2016 | 61 | 1.350 |
Why?
| | Radiopharmaceuticals | 19 | 2020 | 167 | 1.340 |
Why?
| | Lumbar Vertebrae | 4 | 2021 | 234 | 1.270 |
Why?
| | Uterine Neoplasms | 11 | 2010 | 100 | 1.140 |
Why?
| | Educational Measurement | 2 | 2020 | 262 | 1.080 |
Why?
| | Vena Cava, Inferior | 7 | 2021 | 68 | 1.060 |
Why?
| | Venous Thrombosis | 6 | 2023 | 176 | 1.020 |
Why?
| | Treatment Outcome | 71 | 2023 | 10232 | 0.970 |
Why?
| | Lasers, Excimer | 2 | 2022 | 29 | 0.960 |
Why?
| | Renal Dialysis | 2 | 2020 | 423 | 0.950 |
Why?
| | Practice Patterns, Physicians' | 9 | 2021 | 1257 | 0.950 |
Why?
| | Portal Vein | 4 | 2016 | 108 | 0.920 |
Why?
| | Microspheres | 29 | 2013 | 131 | 0.900 |
Why?
| | Prosthesis Design | 7 | 2020 | 293 | 0.890 |
Why?
| | Postoperative Complications | 8 | 2021 | 2475 | 0.840 |
Why?
| | Magnetic Resonance Imaging, Interventional | 8 | 2014 | 23 | 0.830 |
Why?
| | Specialty Boards | 2 | 2020 | 32 | 0.820 |
Why?
| | Total Disc Replacement | 2 | 2020 | 14 | 0.800 |
Why?
| | Leiomyoma | 9 | 2007 | 73 | 0.790 |
Why?
| | Uterus | 7 | 2007 | 207 | 0.780 |
Why?
| | Intervertebral Disc | 3 | 2020 | 39 | 0.780 |
Why?
| | End Stage Liver Disease | 2 | 2021 | 79 | 0.760 |
Why?
| | Forecasting | 1 | 2024 | 360 | 0.760 |
Why?
| | Venous Insufficiency | 3 | 2007 | 12 | 0.730 |
Why?
| | Saphenous Vein | 3 | 2007 | 32 | 0.720 |
Why?
| | Middle Aged | 86 | 2023 | 31087 | 0.710 |
Why?
| | Thromboembolism | 3 | 2017 | 112 | 0.700 |
Why?
| | Medicare | 3 | 2020 | 716 | 0.680 |
Why?
| | Humans | 150 | 2024 | 129527 | 0.680 |
Why?
| | Spinal Fusion | 3 | 2021 | 231 | 0.670 |
Why?
| | Prosthesis Implantation | 3 | 2017 | 147 | 0.650 |
Why?
| | Laser Therapy | 3 | 2007 | 129 | 0.640 |
Why?
| | Intervertebral Disc Displacement | 1 | 2020 | 39 | 0.640 |
Why?
| | Diagnostic Imaging | 4 | 2024 | 326 | 0.640 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2020 | 47 | 0.630 |
Why?
| | Endovascular Procedures | 5 | 2020 | 301 | 0.620 |
Why?
| | Graft Occlusion, Vascular | 2 | 2018 | 41 | 0.600 |
Why?
| | Medicine | 1 | 2020 | 117 | 0.600 |
Why?
| | Magnetic Resonance Angiography | 10 | 2014 | 234 | 0.600 |
Why?
| | Venous Thromboembolism | 4 | 2017 | 287 | 0.590 |
Why?
| | Low Back Pain | 1 | 2020 | 105 | 0.580 |
Why?
| | Ultrasonography, Interventional | 3 | 2016 | 130 | 0.580 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 16 | 0.570 |
Why?
| | Female | 102 | 2023 | 68650 | 0.570 |
Why?
| | Magnetic Resonance Imaging | 27 | 2023 | 3392 | 0.560 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2019 | 206 | 0.560 |
Why?
| | Time Factors | 25 | 2021 | 6530 | 0.550 |
Why?
| | Spine | 1 | 2019 | 160 | 0.550 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 61 | 0.540 |
Why?
| | Aged | 63 | 2021 | 22063 | 0.540 |
Why?
| | Ascites | 2 | 2016 | 44 | 0.540 |
Why?
| | Retrospective Studies | 37 | 2023 | 14532 | 0.540 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2021 | 123 | 0.530 |
Why?
| | Stents | 8 | 2015 | 504 | 0.520 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 206 | 0.520 |
Why?
| | Tomography, X-Ray Computed | 24 | 2018 | 2503 | 0.510 |
Why?
| | Aged, 80 and over | 34 | 2021 | 7052 | 0.510 |
Why?
| | Male | 87 | 2023 | 63586 | 0.490 |
Why?
| | Brachytherapy | 8 | 2008 | 104 | 0.490 |
Why?
| | Digestive System Neoplasms | 1 | 2015 | 8 | 0.490 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2016 | 33 | 0.490 |
Why?
| | Adult | 59 | 2021 | 35505 | 0.490 |
Why?
| | Social Media | 1 | 2017 | 141 | 0.460 |
Why?
| | Cholestasis | 2 | 2015 | 231 | 0.460 |
Why?
| | United States | 16 | 2024 | 13865 | 0.450 |
Why?
| | Radiology | 2 | 2024 | 159 | 0.440 |
Why?
| | Radiation Dosage | 6 | 2020 | 154 | 0.430 |
Why?
| | Clinical Competence | 2 | 2019 | 1015 | 0.410 |
Why?
| | Thrombosis | 4 | 2022 | 348 | 0.400 |
Why?
| | Liver Neoplasms, Experimental | 4 | 2020 | 28 | 0.400 |
Why?
| | Ovary | 3 | 2003 | 209 | 0.380 |
Why?
| | Imaging, Three-Dimensional | 5 | 2011 | 530 | 0.370 |
Why?
| | Angiography | 11 | 2011 | 197 | 0.370 |
Why?
| | Risk Factors | 18 | 2020 | 9779 | 0.360 |
Why?
| | Liver Cirrhosis | 6 | 2019 | 281 | 0.360 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 77 | 0.340 |
Why?
| | Uterine Artery Embolization | 1 | 2010 | 6 | 0.340 |
Why?
| | Vascular System Injuries | 3 | 2016 | 73 | 0.330 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2007 | 132 | 0.330 |
Why?
| | Drainage | 3 | 2019 | 164 | 0.330 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2021 | 218 | 0.330 |
Why?
| | Perfusion Imaging | 1 | 2010 | 56 | 0.330 |
Why?
| | Chicago | 6 | 2017 | 57 | 0.330 |
Why?
| | Angioplasty | 3 | 2007 | 47 | 0.330 |
Why?
| | Adenoma, Islet Cell | 1 | 2009 | 7 | 0.320 |
Why?
| | Liver Abscess | 1 | 2009 | 6 | 0.320 |
Why?
| | Neoplasms | 5 | 2023 | 2450 | 0.320 |
Why?
| | Predictive Value of Tests | 11 | 2020 | 1950 | 0.320 |
Why?
| | Observer Variation | 3 | 2010 | 314 | 0.320 |
Why?
| | Thyroid Gland | 1 | 2009 | 92 | 0.310 |
Why?
| | Polyvinyl Alcohol | 3 | 2005 | 16 | 0.310 |
Why?
| | Contrast Media | 12 | 2016 | 393 | 0.300 |
Why?
| | Hepatic Veins | 1 | 2008 | 31 | 0.300 |
Why?
| | Phlebography | 6 | 2015 | 37 | 0.300 |
Why?
| | Rabbits | 12 | 2020 | 769 | 0.300 |
Why?
| | Gelatin | 2 | 2005 | 42 | 0.290 |
Why?
| | Portography | 4 | 2016 | 11 | 0.290 |
Why?
| | Neovascularization, Pathologic | 5 | 2009 | 292 | 0.290 |
Why?
| | Databases, Factual | 7 | 2020 | 1261 | 0.280 |
Why?
| | Pancreatic Neoplasms | 3 | 2010 | 875 | 0.280 |
Why?
| | Patient Selection | 6 | 2020 | 659 | 0.280 |
Why?
| | Lymphangioma, Cystic | 1 | 2007 | 4 | 0.280 |
Why?
| | Prosthesis Failure | 3 | 2017 | 113 | 0.270 |
Why?
| | Liver Transplantation | 5 | 2015 | 833 | 0.270 |
Why?
| | Antineoplastic Agents | 6 | 2014 | 2044 | 0.270 |
Why?
| | Catheterization | 7 | 2013 | 176 | 0.270 |
Why?
| | Aortography | 1 | 2007 | 51 | 0.270 |
Why?
| | Referral and Consultation | 1 | 2012 | 732 | 0.270 |
Why?
| | Logistic Models | 8 | 2021 | 1983 | 0.270 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 99 | 0.260 |
Why?
| | Hepatic Artery | 5 | 2010 | 58 | 0.260 |
Why?
| | Thrombolytic Therapy | 4 | 2023 | 137 | 0.260 |
Why?
| | Linear Models | 4 | 2017 | 818 | 0.260 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 305 | 0.250 |
Why?
| | Acrylic Resins | 1 | 2005 | 44 | 0.240 |
Why?
| | Radiation Injuries | 5 | 2010 | 135 | 0.240 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2007 | 197 | 0.240 |
Why?
| | Internship and Residency | 2 | 2019 | 1049 | 0.230 |
Why?
| | Blister | 1 | 2004 | 41 | 0.220 |
Why?
| | Cohort Studies | 7 | 2023 | 5423 | 0.220 |
Why?
| | Survival Rate | 12 | 2018 | 1870 | 0.220 |
Why?
| | Arteries | 7 | 2013 | 266 | 0.220 |
Why?
| | Multivariate Analysis | 7 | 2017 | 1491 | 0.220 |
Why?
| | Postphlebitic Syndrome | 1 | 2023 | 2 | 0.210 |
Why?
| | Postthrombotic Syndrome | 1 | 2023 | 11 | 0.200 |
Why?
| | Jugular Veins | 3 | 1997 | 41 | 0.200 |
Why?
| | Neoplasm Staging | 8 | 2014 | 1281 | 0.200 |
Why?
| | Prospective Studies | 16 | 2023 | 7150 | 0.200 |
Why?
| | Elasticity Imaging Techniques | 1 | 2022 | 48 | 0.190 |
Why?
| | Fluoroscopy | 2 | 2016 | 157 | 0.190 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 1001 | 0.190 |
Why?
| | Education, Medical, Continuing | 2 | 2017 | 121 | 0.190 |
Why?
| | Catheters | 3 | 2023 | 70 | 0.190 |
Why?
| | Kaplan-Meier Estimate | 9 | 2015 | 850 | 0.190 |
Why?
| | Neoplasms, Experimental | 2 | 2013 | 170 | 0.190 |
Why?
| | Disease Progression | 14 | 2014 | 2628 | 0.190 |
Why?
| | Chi-Square Distribution | 6 | 2014 | 515 | 0.180 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 287 | 0.180 |
Why?
| | Constriction, Pathologic | 3 | 2019 | 234 | 0.180 |
Why?
| | Liver | 7 | 2013 | 1836 | 0.180 |
Why?
| | Reoperation | 4 | 2019 | 542 | 0.180 |
Why?
| | Vascular Patency | 3 | 2018 | 102 | 0.180 |
Why?
| | Angiography, Digital Subtraction | 6 | 2014 | 43 | 0.180 |
Why?
| | Adolescent | 16 | 2021 | 20409 | 0.180 |
Why?
| | Medical Oncology | 2 | 2013 | 267 | 0.180 |
Why?
| | Ultrasonography, Doppler, Color | 3 | 2008 | 38 | 0.180 |
Why?
| | Disease Models, Animal | 6 | 2016 | 4073 | 0.170 |
Why?
| | alpha-Fetoproteins | 2 | 2012 | 42 | 0.170 |
Why?
| | Catheter Ablation | 1 | 2004 | 336 | 0.170 |
Why?
| | Liver Diseases | 2 | 2007 | 291 | 0.170 |
Why?
| | Surgical Stomas | 1 | 2000 | 7 | 0.170 |
Why?
| | Sensitivity and Specificity | 9 | 2012 | 1842 | 0.170 |
Why?
| | Colostomy | 1 | 2000 | 27 | 0.170 |
Why?
| | Varicose Veins | 1 | 2000 | 17 | 0.170 |
Why?
| | Infusions, Intra-Arterial | 9 | 2010 | 53 | 0.170 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2020 | 87 | 0.170 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 14 | 0.160 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 201 | 0.160 |
Why?
| | Lumbosacral Region | 1 | 2020 | 55 | 0.160 |
Why?
| | Hemorrhage | 2 | 2023 | 680 | 0.160 |
Why?
| | Follow-Up Studies | 11 | 2013 | 4891 | 0.160 |
Why?
| | Budd-Chiari Syndrome | 1 | 1999 | 5 | 0.160 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 113 | 0.160 |
Why?
| | Laminoplasty | 1 | 2019 | 2 | 0.160 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2011 | 251 | 0.160 |
Why?
| | Laminectomy | 1 | 2019 | 29 | 0.160 |
Why?
| | Bile Ducts | 1 | 2019 | 68 | 0.150 |
Why?
| | Young Adult | 8 | 2021 | 12438 | 0.150 |
Why?
| | Iliac Artery | 2 | 2018 | 55 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 143 | 0.150 |
Why?
| | Ohio | 1 | 2019 | 151 | 0.150 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2010 | 98 | 0.150 |
Why?
| | Glass | 3 | 2013 | 43 | 0.150 |
Why?
| | Survival Analysis | 6 | 2011 | 1270 | 0.150 |
Why?
| | Models, Educational | 1 | 2019 | 90 | 0.150 |
Why?
| | Biliary Fistula | 1 | 1998 | 3 | 0.150 |
Why?
| | Mesenteric Veins | 1 | 1998 | 18 | 0.150 |
Why?
| | Urinary Fistula | 1 | 1998 | 9 | 0.140 |
Why?
| | Intestine, Small | 1 | 2019 | 151 | 0.140 |
Why?
| | Fibrin | 2 | 2023 | 70 | 0.140 |
Why?
| | Thrombectomy | 1 | 1998 | 58 | 0.140 |
Why?
| | Writing | 1 | 2019 | 90 | 0.140 |
Why?
| | Liver Circulation | 4 | 2015 | 19 | 0.140 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 195 | 0.140 |
Why?
| | Radiography | 7 | 2012 | 798 | 0.140 |
Why?
| | Pain | 1 | 2003 | 788 | 0.140 |
Why?
| | Treatment Failure | 4 | 2017 | 339 | 0.130 |
Why?
| | Patient Advocacy | 1 | 2017 | 73 | 0.130 |
Why?
| | Drug Utilization | 1 | 2017 | 170 | 0.130 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 22 | 0.130 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 22 | 0.130 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2734 | 0.130 |
Why?
| | History, 20th Century | 1 | 2017 | 295 | 0.130 |
Why?
| | Hospitals | 1 | 2021 | 649 | 0.130 |
Why?
| | Portal Pressure | 1 | 2016 | 4 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2019 | 478 | 0.130 |
Why?
| | Research Design | 3 | 2013 | 1043 | 0.130 |
Why?
| | Lower Extremity | 1 | 2020 | 404 | 0.130 |
Why?
| | Cell Line, Tumor | 7 | 2013 | 3181 | 0.130 |
Why?
| | Anatomic Landmarks | 1 | 2016 | 28 | 0.120 |
Why?
| | Gadolinium DTPA | 5 | 2014 | 50 | 0.120 |
Why?
| | Doxorubicin | 3 | 2013 | 328 | 0.120 |
Why?
| | Balloon Occlusion | 1 | 2016 | 34 | 0.120 |
Why?
| | Finite Element Analysis | 1 | 2016 | 72 | 0.120 |
Why?
| | Reproducibility of Results | 8 | 2011 | 3081 | 0.120 |
Why?
| | Patient Readmission | 1 | 2021 | 667 | 0.120 |
Why?
| | Operative Time | 1 | 2016 | 123 | 0.120 |
Why?
| | Radiation Exposure | 1 | 2016 | 45 | 0.120 |
Why?
| | Aorta | 1 | 2018 | 407 | 0.120 |
Why?
| | Stomach | 2 | 2013 | 107 | 0.120 |
Why?
| | Models, Anatomic | 1 | 2016 | 87 | 0.120 |
Why?
| | Wounds, Nonpenetrating | 4 | 2000 | 273 | 0.120 |
Why?
| | Intraoperative Complications | 1 | 2016 | 129 | 0.120 |
Why?
| | Hospital Mortality | 2 | 2018 | 851 | 0.120 |
Why?
| | Bile Ducts, Intrahepatic | 3 | 2013 | 65 | 0.120 |
Why?
| | Necrosis | 5 | 2020 | 234 | 0.120 |
Why?
| | Dilatation | 1 | 2015 | 62 | 0.120 |
Why?
| | Sex Factors | 2 | 2018 | 1966 | 0.120 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 439 | 0.120 |
Why?
| | Data Interpretation, Statistical | 3 | 2013 | 337 | 0.110 |
Why?
| | Biopsy | 3 | 2014 | 1087 | 0.110 |
Why?
| | Cisplatin | 3 | 2012 | 298 | 0.110 |
Why?
| | Wounds, Gunshot | 1 | 1998 | 213 | 0.110 |
Why?
| | Carotid Artery Injuries | 3 | 2000 | 41 | 0.110 |
Why?
| | Length of Stay | 2 | 2019 | 1132 | 0.110 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 34 | 0.110 |
Why?
| | Kidney Diseases | 1 | 1998 | 382 | 0.110 |
Why?
| | Stress, Mechanical | 1 | 2016 | 461 | 0.110 |
Why?
| | Carbon Dioxide | 1 | 2016 | 260 | 0.110 |
Why?
| | Anticoagulants | 2 | 2017 | 637 | 0.110 |
Why?
| | Magnetite Nanoparticles | 1 | 2013 | 29 | 0.110 |
Why?
| | Ultrasonography | 3 | 2022 | 708 | 0.110 |
Why?
| | Arthroscopy | 3 | 1992 | 207 | 0.110 |
Why?
| | Duodenum | 1 | 2013 | 74 | 0.100 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 458 | 0.100 |
Why?
| | Prevalence | 3 | 2021 | 2561 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2724 | 0.100 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 723 | 0.100 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1559 | 0.100 |
Why?
| | Catheterization, Peripheral | 3 | 2008 | 105 | 0.100 |
Why?
| | Patient Education as Topic | 1 | 2017 | 738 | 0.100 |
Why?
| | Proportional Hazards Models | 5 | 2014 | 1196 | 0.100 |
Why?
| | Regional Blood Flow | 3 | 2007 | 464 | 0.100 |
Why?
| | Shoulder Injuries | 1 | 1992 | 57 | 0.100 |
Why?
| | Acromion | 1 | 1992 | 7 | 0.100 |
Why?
| | Electroporation | 1 | 2012 | 37 | 0.090 |
Why?
| | Fibromuscular Dysplasia | 1 | 2011 | 7 | 0.090 |
Why?
| | Rotator Cuff | 1 | 1992 | 46 | 0.090 |
Why?
| | Tendon Injuries | 1 | 1992 | 68 | 0.090 |
Why?
| | Respiratory-Gated Imaging Techniques | 1 | 2011 | 10 | 0.090 |
Why?
| | Prognosis | 5 | 2010 | 3772 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1548 | 0.090 |
Why?
| | Yttrium | 1 | 2010 | 5 | 0.090 |
Why?
| | Research Report | 1 | 2011 | 79 | 0.090 |
Why?
| | Neuroendocrine Tumors | 1 | 2011 | 99 | 0.090 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 77 | 0.090 |
Why?
| | Injections, Intra-Arterial | 5 | 2012 | 25 | 0.080 |
Why?
| | Tumor Burden | 3 | 2020 | 287 | 0.080 |
Why?
| | Biomarkers, Tumor | 3 | 2012 | 1159 | 0.080 |
Why?
| | Practice Guidelines as Topic | 5 | 2013 | 1510 | 0.080 |
Why?
| | Punctures | 1 | 2010 | 40 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2014 | 401 | 0.080 |
Why?
| | Animals | 14 | 2020 | 35334 | 0.080 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 67 | 0.080 |
Why?
| | Gastrostomy | 2 | 2009 | 108 | 0.080 |
Why?
| | Recurrence | 3 | 2021 | 1011 | 0.080 |
Why?
| | Pancreatic Pseudocyst | 1 | 2009 | 13 | 0.080 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2101 | 0.080 |
Why?
| | Bilirubin | 3 | 2010 | 95 | 0.080 |
Why?
| | Palliative Care | 1 | 2015 | 704 | 0.080 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 228 | 0.070 |
Why?
| | Radiation Pneumonitis | 1 | 2008 | 28 | 0.070 |
Why?
| | Liver Function Tests | 3 | 2015 | 112 | 0.070 |
Why?
| | Biliary Tract | 1 | 2008 | 15 | 0.070 |
Why?
| | Radiotherapy Dosage | 4 | 2010 | 251 | 0.070 |
Why?
| | Knee Injuries | 1 | 1989 | 99 | 0.070 |
Why?
| | Maximum Allowable Concentration | 1 | 2007 | 14 | 0.070 |
Why?
| | Subtraction Technique | 1 | 2007 | 23 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1422 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 253 | 0.070 |
Why?
| | Endpoint Determination | 3 | 2013 | 76 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2008 | 162 | 0.070 |
Why?
| | Acute Disease | 2 | 2021 | 975 | 0.070 |
Why?
| | Vacuum Curettage | 1 | 2007 | 5 | 0.070 |
Why?
| | Incidence | 3 | 2009 | 2643 | 0.070 |
Why?
| | Image Enhancement | 4 | 2011 | 167 | 0.070 |
Why?
| | Ultrasonography, Doppler, Duplex | 2 | 2004 | 43 | 0.070 |
Why?
| | Radiotherapy | 1 | 2008 | 185 | 0.070 |
Why?
| | Catheterization, Central Venous | 2 | 1999 | 104 | 0.070 |
Why?
| | Leiomyomatosis | 1 | 2006 | 4 | 0.070 |
Why?
| | Credentialing | 1 | 2006 | 16 | 0.070 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 275 | 0.070 |
Why?
| | Iron | 1 | 2008 | 283 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 316 | 0.060 |
Why?
| | Hospitalization | 3 | 2021 | 2076 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 312 | 0.060 |
Why?
| | Personnel Selection | 1 | 2006 | 70 | 0.060 |
Why?
| | Knee Joint | 1 | 1989 | 371 | 0.060 |
Why?
| | Ethics, Research | 1 | 2005 | 31 | 0.060 |
Why?
| | Decision Making | 1 | 2012 | 860 | 0.060 |
Why?
| | Organ Size | 3 | 2013 | 455 | 0.060 |
Why?
| | Heart Failure | 1 | 2018 | 2143 | 0.060 |
Why?
| | Kidney Transplantation | 1 | 2011 | 669 | 0.060 |
Why?
| | Postmenopause | 1 | 2007 | 349 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 98 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1201 | 0.060 |
Why?
| | Odds Ratio | 2 | 2017 | 1018 | 0.060 |
Why?
| | Dose-Response Relationship, Radiation | 3 | 2008 | 133 | 0.050 |
Why?
| | Pilot Projects | 4 | 2009 | 1594 | 0.050 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2003 | 11 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2006 | 278 | 0.050 |
Why?
| | Ischemia | 1 | 2006 | 405 | 0.050 |
Why?
| | Iliac Vein | 1 | 2023 | 11 | 0.050 |
Why?
| | Illinois | 3 | 2009 | 42 | 0.050 |
Why?
| | Femoral Vein | 1 | 2023 | 32 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 67 | 0.050 |
Why?
| | Menisci, Tibial | 2 | 1995 | 59 | 0.050 |
Why?
| | Aneurysm, False | 2 | 2000 | 47 | 0.050 |
Why?
| | Elasticity | 1 | 2022 | 193 | 0.050 |
Why?
| | Pelvis | 1 | 2002 | 104 | 0.050 |
Why?
| | Hepatectomy | 2 | 2013 | 212 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 744 | 0.050 |
Why?
| | Feasibility Studies | 3 | 2011 | 869 | 0.050 |
Why?
| | Drug Stability | 2 | 2013 | 160 | 0.050 |
Why?
| | Confidence Intervals | 2 | 2013 | 316 | 0.040 |
Why?
| | World Health Organization | 2 | 2012 | 110 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 541 | 0.040 |
Why?
| | Europe | 2 | 2012 | 362 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.040 |
Why?
| | Carotid Artery, Internal | 1 | 2000 | 41 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2013 | 647 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 41 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 46 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 57 | 0.040 |
Why?
| | Hepatic Encephalopathy | 1 | 1999 | 20 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2000 | 121 | 0.040 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 715 | 0.040 |
Why?
| | Tomography, Emission-Computed | 2 | 2009 | 66 | 0.040 |
Why?
| | Tracheoesophageal Fistula | 1 | 1999 | 33 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 150 | 0.040 |
Why?
| | Multiple Organ Failure | 1 | 1999 | 123 | 0.040 |
Why?
| | Liver Failure | 1 | 1999 | 91 | 0.040 |
Why?
| | Streptokinase | 1 | 1998 | 10 | 0.040 |
Why?
| | Serum Albumin | 1 | 1999 | 149 | 0.040 |
Why?
| | Equipment Design | 2 | 2012 | 514 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2011 | 1286 | 0.040 |
Why?
| | Ethiodized Oil | 2 | 2008 | 5 | 0.040 |
Why?
| | Population Surveillance | 1 | 2001 | 440 | 0.040 |
Why?
| | Postoperative Hemorrhage | 1 | 1999 | 88 | 0.040 |
Why?
| | Swine | 2 | 2016 | 760 | 0.040 |
Why?
| | Mitomycin | 2 | 2008 | 32 | 0.040 |
Why?
| | Guidelines as Topic | 2 | 2010 | 261 | 0.040 |
Why?
| | Nervous System Diseases | 2 | 2017 | 252 | 0.030 |
Why?
| | Cartilage Diseases | 2 | 1995 | 39 | 0.030 |
Why?
| | Cause of Death | 1 | 1999 | 395 | 0.030 |
Why?
| | Intracranial Hypertension | 1 | 1997 | 37 | 0.030 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1997 | 123 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 1998 | 118 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 165 | 0.030 |
Why?
| | Demography | 1 | 2017 | 279 | 0.030 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1997 | 135 | 0.030 |
Why?
| | Positron-Emission Tomography | 2 | 2008 | 282 | 0.030 |
Why?
| | Recovery of Function | 1 | 2000 | 644 | 0.030 |
Why?
| | Databases as Topic | 2 | 2010 | 59 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 507 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 264 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3383 | 0.030 |
Why?
| | Lung | 1 | 2008 | 3928 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 262 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 476 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 192 | 0.030 |
Why?
| | Phantoms, Imaging | 2 | 2008 | 137 | 0.030 |
Why?
| | Cysts | 1 | 1995 | 108 | 0.030 |
Why?
| | Embolism | 2 | 2008 | 40 | 0.030 |
Why?
| | Preoperative Care | 1 | 2016 | 337 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 514 | 0.030 |
Why?
| | Ablation Techniques | 1 | 2013 | 35 | 0.030 |
Why?
| | Vascular Surgical Procedures | 1 | 2016 | 295 | 0.030 |
Why?
| | Eligibility Determination | 1 | 2013 | 63 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 208 | 0.020 |
Why?
| | Scapula | 1 | 1992 | 45 | 0.020 |
Why?
| | Nausea | 1 | 2011 | 111 | 0.020 |
Why?
| | Muscular Diseases | 1 | 1992 | 109 | 0.020 |
Why?
| | Vomiting | 1 | 2011 | 129 | 0.020 |
Why?
| | Biomarkers | 2 | 2014 | 3968 | 0.020 |
Why?
| | International Agencies | 1 | 2010 | 29 | 0.020 |
Why?
| | Diarrhea | 1 | 2011 | 180 | 0.020 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2010 | 72 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2013 | 378 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2011 | 142 | 0.020 |
Why?
| | Risk Assessment | 2 | 2009 | 3255 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5078 | 0.020 |
Why?
| | Registries | 1 | 2018 | 1902 | 0.020 |
Why?
| | Standard of Care | 1 | 2010 | 71 | 0.020 |
Why?
| | Yttrium Isotopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 146 | 0.020 |
Why?
| | Fatigue | 1 | 2011 | 319 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 1992 | 368 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 324 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3150 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1722 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 203 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 503 | 0.020 |
Why?
| | Fibula | 1 | 1989 | 47 | 0.020 |
Why?
| | Ligaments, Articular | 1 | 1989 | 50 | 0.020 |
Why?
| | Rhenium | 1 | 2008 | 4 | 0.020 |
Why?
| | Radioisotopes | 1 | 2008 | 30 | 0.020 |
Why?
| | Iohexol | 1 | 2008 | 19 | 0.020 |
Why?
| | Body Burden | 1 | 2007 | 8 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 315 | 0.020 |
Why?
| | Hysterosalpingography | 1 | 2007 | 6 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2393 | 0.020 |
Why?
| | Tibia | 1 | 1989 | 168 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 994 | 0.020 |
Why?
| | Hindlimb | 1 | 2008 | 125 | 0.020 |
Why?
| | Injections | 1 | 2008 | 171 | 0.020 |
Why?
| | Celiac Artery | 1 | 2007 | 10 | 0.020 |
Why?
| | Mesenteric Arteries | 1 | 2007 | 17 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2007 | 130 | 0.020 |
Why?
| | Femur | 1 | 1989 | 243 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 89 | 0.020 |
Why?
| | Injury Severity Score | 2 | 2000 | 510 | 0.020 |
Why?
| | Weight Loss | 1 | 2011 | 738 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 931 | 0.020 |
Why?
| | Cartilage, Articular | 1 | 1989 | 292 | 0.020 |
Why?
| | Retreatment | 1 | 2005 | 70 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1368 | 0.010 |
Why?
| | Rats | 1 | 2013 | 5470 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2007 | 609 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1614 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 10499 | 0.010 |
Why?
| | Child | 3 | 2017 | 20932 | 0.010 |
Why?
| | Radiography, Abdominal | 1 | 2001 | 45 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2002 | 406 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 375 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2000 | 43 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 85 | 0.010 |
Why?
| | Pneumonia, Aspiration | 1 | 1999 | 18 | 0.010 |
Why?
| | Hematoma | 1 | 1999 | 53 | 0.010 |
Why?
| | Endoscopy | 1 | 2001 | 290 | 0.010 |
Why?
| | Veins | 1 | 1999 | 60 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 72 | 0.010 |
Why?
| | Aortic Diseases | 1 | 2000 | 114 | 0.010 |
Why?
| | Esophageal Stenosis | 1 | 1999 | 51 | 0.010 |
Why?
| | Decision Trees | 1 | 1998 | 90 | 0.010 |
Why?
| | Arm | 1 | 1999 | 106 | 0.010 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1999 | 125 | 0.010 |
Why?
| | Cerebral Infarction | 1 | 1997 | 41 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1997 | 66 | 0.010 |
Why?
| | Los Angeles | 1 | 1997 | 63 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1997 | 112 | 0.010 |
Why?
| | Carotid Artery Diseases | 1 | 1997 | 64 | 0.010 |
Why?
| | Intracranial Pressure | 1 | 1997 | 45 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 186 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1998 | 253 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1997 | 165 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1997 | 101 | 0.010 |
Why?
| | Carotid Stenosis | 1 | 1997 | 84 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1997 | 92 | 0.010 |
Why?
| | HIV | 1 | 1997 | 227 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1997 | 196 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1997 | 323 | 0.010 |
Why?
| | Heparin | 1 | 1997 | 253 | 0.010 |
Why?
| | Cluster Analysis | 1 | 1997 | 483 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1997 | 151 | 0.010 |
Why?
| | Synovial Cyst | 1 | 1995 | 3 | 0.010 |
Why?
| | DNA, Viral | 1 | 1997 | 347 | 0.010 |
Why?
| | Brain Ischemia | 1 | 1997 | 321 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1997 | 309 | 0.010 |
Why?
| | Brain Injuries | 1 | 1997 | 469 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2002 | 5429 | 0.010 |
Why?
| | Tibial Meniscus Injuries | 1 | 1990 | 45 | 0.010 |
Why?
| | Postoperative Period | 1 | 1990 | 329 | 0.000 |
Why?
|
|
Ryu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|